目次

Table of Contents

1. Executive Summary

2. Drugs for Immunotherapy Market Characteristics

3. Drugs for Immunotherapy Market Trends And Strategies

4. Impact Of COVID-19 On Drugs for Immunotherapy

5. Drugs for Immunotherapy Market Size And Growth
5.1. Global Drugs for Immunotherapy Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Drugs for Immunotherapy Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Drugs for Immunotherapy Market Segmentation
6.1. Global Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Monoclonal antibodies
Interferons
Interleukins
Vaccines
Checkpoint Inhibitors
Others
6.2. Global Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
6.3. Global Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospitals & Clinics
Ambulatory Surgical Centers
Others

7. Drugs for Immunotherapy Market Regional And Country Analysis
7.1. Global Drugs for Immunotherapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Drugs for Immunotherapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Drugs for Immunotherapy Market
8.1. Asia-Pacific Drugs for Immunotherapy Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.4. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Drugs for Immunotherapy Market
9.1. China Drugs for Immunotherapy Market Overview
9.2. China Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.4. China Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Drugs for Immunotherapy Market
10.1. India Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.3. India Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Drugs for Immunotherapy Market
11.1. Japan Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.3. Japan Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Drugs for Immunotherapy Market
12.1. Australia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.3. Australia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Drugs for Immunotherapy Market
13.1. Indonesia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.3. Indonesia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Drugs for Immunotherapy Market
14.1. South Korea Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.3. South Korea Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Drugs for Immunotherapy Market
15.1. Western Europe Drugs for Immunotherapy Market Overview
15.2. Western Europe Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.4. Western Europe Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Drugs for Immunotherapy Market
16.1. UK Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.3. UK Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Drugs for Immunotherapy Market
17.1. Germany Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.3. Germany Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Drugs for Immunotherapy Market
18.5. France Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.6. France Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.7. France Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Drugs for Immunotherapy Market
19.1. Eastern Europe Drugs for Immunotherapy Market Overview
19.2. Eastern Europe Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.4. Eastern Europe Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Drugs for Immunotherapy Market
20.1. Russia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.3. Russia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Drugs for Immunotherapy Market
21.1. North America Drugs for Immunotherapy Market Overview
21.2. North America Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.4. North America Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Drugs for Immunotherapy Market
22.1. USA Drugs for Immunotherapy Market Overview
22.2. USA Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.4. USA Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Drugs for Immunotherapy Market
23.1. South America Drugs for Immunotherapy Market Overview
23.2. South America Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.4. South America Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Drugs for Immunotherapy Market
24.1. Brazil Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.3. Brazil Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Drugs for Immunotherapy Market
25.1. Middle East Drugs for Immunotherapy Market Overview
25.2. Middle East Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.4. Middle East Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Drugs for Immunotherapy Market
26.1. Africa Drugs for Immunotherapy Market Overview
26.2. Africa Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.4. Africa Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Drugs for Immunotherapy Market Competitive Landscape And Company Profiles
27.1. Drugs for Immunotherapy Market Competitive Landscape
27.2. Drugs for Immunotherapy Market Company Profiles
27.2.1. F. Hoffmann-La Roche Ltd
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Novartis AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Amgen, Inc
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. AbbVie, Inc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Merck & Co., Inc
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Drugs for Immunotherapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Drugs for Immunotherapy Market

30. Drugs for Immunotherapy Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global Drugs for Immunotherapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Drugs for Immunotherapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: Asia-Pacific, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: Asia-Pacific, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: China, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: China, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: China, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: India, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: India, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: India, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Japan, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: Japan, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Japan, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: Australia, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: Australia, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: Australia, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: Indonesia, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: Indonesia, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: Indonesia, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: South Korea, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: South Korea, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 28: South Korea, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 29: Western Europe, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 30: Western Europe, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 31: Western Europe, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 32: UK, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 33: UK, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 34: UK, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 35: Germany, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 36: Germany, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 37: Germany, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 38: France, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 39: France, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 40: France, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 41: Eastern Europe, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 42: Eastern Europe, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 43: Eastern Europe, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 44: Russia, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 45: Russia, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 46: Russia, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 47: North America, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 48: North America, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 49: North America, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 50: USA, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 51: USA, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 52: USA, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 53: South America, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 54: South America, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 55: South America, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 56: Brazil, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 57: Brazil, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 58: Brazil, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 59: Middle East, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 60: Middle East, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 61: Middle East, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 62: Africa, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 63: Africa, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 64: Africa, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 65: F. Hoffmann-La Roche Ltd Financial Performance
Table 66: Novartis AG Financial Performance
Table 67: Amgen, Inc Financial Performance
Table 68: AbbVie, Inc Financial Performance
Table 69: Merck & Co., Inc Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global Drugs for Immunotherapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Drugs for Immunotherapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: Asia-Pacific, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: Asia-Pacific, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: China, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: China, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: China, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: India, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: India, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: India, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Japan, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: Japan, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Japan, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: Australia, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: Australia, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: Australia, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: Indonesia, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: Indonesia, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: Indonesia, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: South Korea, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: South Korea, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 28: South Korea, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 29: Western Europe, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 30: Western Europe, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 31: Western Europe, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 32: UK, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 33: UK, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 34: UK, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 35: Germany, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 36: Germany, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 37: Germany, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 38: France, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 39: France, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 40: France, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 41: Eastern Europe, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 42: Eastern Europe, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 43: Eastern Europe, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 44: Russia, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 45: Russia, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 46: Russia, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 47: North America, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 48: North America, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 49: North America, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 50: USA, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 51: USA, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 52: USA, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 53: South America, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 54: South America, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 55: South America, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 56: Brazil, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 57: Brazil, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 58: Brazil, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 59: Middle East, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 60: Middle East, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 61: Middle East, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 62: Africa, Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 63: Africa, Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 64: Africa, Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 65: F. Hoffmann-La Roche Ltd Financial Performance
Figure 66: Novartis AG Financial Performance
Figure 67: Amgen, Inc Financial Performance
Figure 68: AbbVie, Inc Financial Performance
Figure 69: Merck & Co., Inc Financial Performance